Bradley D. Page - 22 Feb 2022 Form 4 Insider Report for Physicians Realty Trust

Role: SVP - General Counsel
Signature: /s/ Christopher M. Bartoli, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 22 Feb 2022
Net transactions value: -$225,768
Form type: 4
Filing time: 23 Feb 2022, 15:23:31 UTC
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DOC	Common shares, $0.01 par value	Options Exercise	$0	+27,693	+161%	$0.000000	44,849	22 Feb 2022	Direct	F1, F2
transaction	DOC	Common shares, $0.01 par value	Tax liability	$225,768	-13,226	-29%	$17.07	31,623	22 Feb 2022	Direct
holding	DOC	Common shares, $0.01 par value						74,648	22 Feb 2022	Represents shares held by the Bradley D. Page and Cheryl M. Page Joint Revocable Trust Dated 1/19/15	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DOC	2019 Performance Based Restricted Share Unit Grant	Options Exercise	$0	-17,507	-100%	$0.000000^*	0	22 Feb 2022	Common shares, $0.01 par value	17,507		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents vesting of the 2019 Performance Based Restricted Share Units granted on March 1, 2019 under the Issuer's Equity Incentive Plan (the "Plan"). Subject to the terms of the grant, the Reporting Person received 27,693 common shares upon vesting.
F2	Includes 492 shares and 345 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on June 30, 2021 and December 31, 2021, respectively, and 19,321 shares transferred to the Bradley D. Page and Cheryl M. Page Joint Revocable Trust Dated January 19, 2015.
F3	Includes shares transferred from the Reporting Person.
F4	March 1, 2019, the Reporting Person was granted 17,507 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Subject to the terms of the grant, the Reporting Person received 27,693 common shares upon vesting.